Form4insider filings, from the source

SEC Form 4 · accession 0001209191-15-035571

ADURO BIOTECH, INC. · ADRO

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Stephen T Isaacs
Officer — President and CEO · Director
Period of report
Apr 20, 2015
Accepted (ET)
Apr 22, 2015 · 5:38 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001435049

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Apr 20, 2015C720—A794D
Common StockF1Apr 20, 2015C26,470—A27,264D
Common StockF1Apr 20, 2015C115,507—A142,771D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Series A Preferred StockF1—Apr 20, 2015C720D——Common Stock7200D
Series A-1 Preferred StockF1—Apr 20, 2015C26,470D——Common Stock26,4700D
Series B Preferred StockF1—Apr 20, 2015C115,507D——Common Stock115,5070D
Series B Preferred Stock Warrant (right to buy)$1.1937Apr 20, 2015D509DApr 15, 2011Apr 15, 2016Series B Preferred Stock3660D
Common Stock Warrant (right to buy)F1$1.66Apr 20, 2015A366AApr 15, 2011Apr 15, 2016Common stock366366D

Explanation of responses